SU-E-T-491: A FLUKA Monte Carlo Computational Model of a Scanning Proton Beam Therapy Nozzle at IU Proton Therapy Center

2012 ◽  
Vol 39 (6Part17) ◽  
pp. 3818-3818 ◽  
Author(s):  
V Moskvin ◽  
C Cheng ◽  
V Anferov ◽  
D Nichiporov ◽  
Q Zhao ◽  
...  
Keyword(s):  
Monte Carlo ◽  
Computational Model ◽  
Proton Beam ◽  
Proton Therapy ◽  
Proton Beam Therapy ◽  
Therapy Center

scholarly journals EP-1404: Early results of proton beam therapy in sarcomas at the West German Proton Therapy Center Essen

2016 ◽  
Vol 119 ◽  
pp. S654-S655
Author(s):  
S. Frisch ◽  
M. Christiaens ◽  
F. Guntrum ◽  
S. Bauer ◽  
C. Blase ◽  
...  
Keyword(s):  
Proton Beam ◽  
Proton Therapy ◽  
Proton Beam Therapy ◽  
The West ◽  
Early Results ◽  
Therapy Center

Abstract ID: 171 A Monte Carlo study to reduce range uncertainty in proton beam therapy via prompt gamma-ray detection

2018 ◽  
Vol 45 ◽  
pp. S2 ◽  
Author(s):  
C. Panaino ◽  
M.J. Taylor ◽  
R. MacKay ◽  
M.J. Merchant ◽  
T. Price ◽  
...  
Keyword(s):  
Monte Carlo ◽  
Proton Beam ◽  
Gamma Ray ◽  
Monte Carlo Study ◽  
Proton Beam Therapy ◽  
Prompt Gamma

scholarly journals [P291] Comparison of beam model implementation methods for commissioning of Monte Carlo code in proton beam therapy centre

2018 ◽  
Vol 52 ◽  
pp. 184
Author(s):  
Magdalena Garbacz ◽  
Jan Gajewski ◽  
Nils Krah ◽  
Angelo Schiavi ◽  
Agata Skrzypek ◽  
...  
Keyword(s):  
Monte Carlo ◽  
Proton Beam ◽  
Proton Beam Therapy ◽  
Beam Model ◽  
Monte Carlo Code

TOPAS Monte Carlo model of MD anderson scanning proton beam for simulation studies in proton therapy

2018 ◽  
Vol 4 (3) ◽  
pp. 037001 ◽  
Author(s):  
J Hartman ◽  
X Zhang ◽  
X R Zhu ◽  
S J Frank ◽  
J J W Lagendijk ◽  
...  
Keyword(s):  
Monte Carlo ◽  
Proton Beam ◽  
Proton Therapy ◽  
Monte Carlo Model ◽  
Simulation Studies ◽  
Md Anderson

Proton beam radiotherapy for uveal melanoma: Results of Curie Institut–Orsay Proton Therapy Center (ICPO)

2006 ◽  
Vol 65 (3) ◽  
pp. 780-787 ◽  
Author(s):  
Rémi Dendale ◽  
Livia Lumbroso-Le Rouic ◽  
Georges Noel ◽  
Loïc Feuvret ◽  
Christine Levy ◽  
...  
Keyword(s):  
Proton Beam ◽  
Uveal Melanoma ◽  
Proton Therapy ◽  
Proton Beam Radiotherapy ◽  
Therapy Center

scholarly journals A Comprehensive Survey of Proton Beam Therapy Research and Development in Iran

2021 ◽  
Author(s):  
Elham Piruzan ◽  
Naser Vosoughi ◽  
Hojjat Mahani
Keyword(s):  
Research And Development ◽  
Proton Beam ◽  
Swot Analysis ◽  
Dose Calculation ◽  
Proton Beam Therapy ◽  
Conventional Radiotherapy ◽  
Bibliographic Data ◽  
Ion Therapy ◽  
Comprehensive Survey ◽  
Therapy Center

Purpose: Proton Beam Therapy (PBT) is an emerging radiotherapy technique using beams of proton to treat cancer. As the first report addressing the topic, the principal aim is to highlight the present status of PBT research and development in Iran as a developing country. Materials and Methods: To do so, the demand for PBT in Iran and Iran National Ion Therapy Center (IRNitc) was investigated and introduced. Then, Scopus and PubMed were searched for studies that dealt with PBT research in Iran and subsequently 6 major subfields of interest were identified. Furthermore, international collaborations were extracted from the bibliographic data. To combine both research and development sides, a SWOT analysis was performed through collecting viewpoints of 48 radiotherapy experts about PBT, and then strengths, weaknesses, opportunities, and threats of it were examined. Results: Iran contributes to approximately 1% of global PBT sciences. Proton dose calculation using Monte Carlo simulation is the dominant subject of interest for Iranian researchers. Italy is recognized as the major foreign partner in PBT researches. Clinical advantages over conventional radiotherapy modalities are the main strength of PBT development in Iran while the high installation cost remains the most weakness. Finally, 10 general considerations for the launching of a PBT facility in Iran were presented based upon both Iranian experts’ viewpoints and IAEA recommendations. Conclusion: This research reveals that while PBT research and development in Iran are still in their infancy, there are promising trends in both the research and development sides of PBT.

scholarly journals An Iterating Method to Calculate the Geometry of Range Modulation Wheel in Passive Proton Therapy

2019 ◽  
pp. 1-11
Author(s):  
Zahra Sadat Tabatabaeian ◽  
Mahdi Sadeghi ◽  
Mohammad Reza Ghasemi
Keyword(s):  
Monte Carlo Simulation ◽  
Monte Carlo ◽  
Penetration Depth ◽  
Proton Beam ◽  
Proton Therapy ◽  
Bragg Peak ◽  
Particle Energy ◽  
Absorption Energy ◽  
Energy Proton ◽  
Spread Out Bragg Peak

In the passive method of proton therapy, range modulation wheel is used to scatter the single energy proton beam. It rounds and scatters the single energy proton beam to the spectrum of particles that covers cancerous tissue by a change in penetration depth. Geant4 is a Monte Carlo simulation platform for studying particles behaviour in a matter. We simulated proton therapy nozzle with Geant4. Geometric properties of this nozzle have some effects on this beam absorption plot. Concerning the relation between penetration depth and proton particle energy, we have designed a range modulation wheel to have an approximately flat plot of absorption energy. An iterative algorithm programming helped us to calculate the weight and thickness of each sector of range modulation wheel. Flatness and practical range are calculated for resulting spread-out Bragg peak.

SU-FF-T-442: Validation of the Monte Carlo Model of the Passive Scattering Nozzles at the Proton Therapy Center Houston

2007 ◽  
Vol 34 (6Part14) ◽  
pp. 2503-2503
Author(s):  
U Titt ◽  
N Sahoo ◽  
R Zhu ◽  
X Ding ◽  
Y Zheng ◽  
...  
Keyword(s):  
Monte Carlo ◽  
Proton Therapy ◽  
Monte Carlo Model ◽  
Therapy Center ◽  
Passive Scattering

scholarly journals PS1 - 183 Recommendations for the Referral of Patients from Proton Beam Therapy, an Alberta Health Services Report: A Model for Canada?

2016 ◽  
Vol 43 (S4) ◽  
pp. S11-S11
Author(s):  
S. Patel ◽  
X. Kostaras ◽  
M. Parliament ◽  
I.A. Olivotto ◽  
R. Nordal ◽  
...  
Keyword(s):  
Health Services ◽  
Proton Beam ◽  
Proton Therapy ◽  
Proton Beam Therapy ◽  
Sufficient Evidence ◽  
Draft Report ◽  
Term Survival ◽  
Travel Abroad ◽  
Alberta Health

Proton beam therapy (PBT) offers compelling advantages in physical dose distribution compared to photon therapy. There are increasing numbers of gantry-based proton facilities worldwide but no such facilities exist in Canada. To access PBT, Canadian patients must travel abroad for treatment at high cost. In the face of limited access, this report seeks to provide recommendations for the selection of patients most likely to benefit from PBT and suggests an out-of-country referral process. METHODS: A systematic literature search for studies between January 1990 and May 2014 evaluating clinical outcomes after PBT. A draft report was developed through review of evidence, externally reviewed, and approved by the Alberta Health Services Cancer Care Proton Therapy Guidelines steering committee. RESULTS: Proton therapy is often used to treat tumours close to radiosensitive tissues, and children at risk of developing significant late effects of radiation therapy (RT). Local control rates with PBT appear similar to or, in some cases, higher than photon RT in uncontrolled and retrospective studies. Randomized trials comparing equivalent doses of PBT and photon RT are not available. SUMMARY: Referral for PBT is recommended for patients being treated with curative intent, with an expectation for long-term survival, and who are able and willing to travel abroad to a proton facility. Commonly accepted indications for referral include chordoma and chondrosarcoma, intraocular melanoma, and solid tumours in children and adolescents occurring in patients with greatest risk of long-term sequelae. Current data do not provide sufficient evidence to recommend routine referral of patients with most head and neck, breast, lung, gastrointestinal tract, and pelvic cancers including prostate cancer. It is recommended that all referrals be considered by a multidisciplinary team to select appropriate cases.

Sign in / Sign up

Export Citation Format

Share Document